Covid-19: Should doctors recommend treatments and vaccines when full data are not publicly available?
Authors
Johnson, Raymond M. Healy, David, 1954-
Johnson, Raymond M.
Healy, David, 1954-
Advisor
Date
24/08/2020
Embargo until
Language
Book title
Publisher
BMJ
Peer Reviewed
Type
Article
Research Area
Jurisdiction
Collections
Other Titles
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
With knowledge of covid-19 less than a year old, treatment remains fraught with uncertainty. Preprint data and adaptive clinical trials are imperfect but can guide active decision making in life-or-death situations, says Raymond M Johnson. But Peter Doshi and David Healy argue that doctors and professional societies should state that, without complete data transparency, they will not endorse covid-19 products as being based on science.
Citations
Altmetric: